Related Experiment Video

Updated: Aug 23, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

Teru Hideshima1, Kenneth C Anderson

  • 1Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.

Nature Reviews. Cancer
|December 3, 2002
PubMed

Insights

Novel therapies targeting the bone marrow microenvironment are needed for multiple myeloma, a largely incurable cancer. Understanding cell-host interactions offers a new treatment framework to overcome drug resistance and improve patient outcomes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Hematology

Background:

  • Multiple myeloma is a hematologic malignancy with limited curative options using conventional therapies.
  • Drug resistance and disease progression are significant challenges in multiple myeloma treatment.
  • The bone marrow microenvironment plays a critical role in myeloma cell survival and proliferation.

Purpose of the Study:

  • To explore novel therapeutic strategies for multiple myeloma.
  • To investigate the molecular mechanisms of multiple myeloma cell-host interactions within the bone marrow.
  • To develop a treatment model targeting the tumor microenvironment to enhance therapeutic efficacy.

Main Methods:

  • Review of recent studies on multiple myeloma pathogenesis.
  • Analysis of molecular mechanisms regulating cancer cell-host interactions.
  • Framework development for microenvironment-targeted therapies.

Main Results:

  • Characterization of molecular pathways governing multiple myeloma cell-host interactions.
  • Identification of the bone marrow microenvironment as a key regulator of tumor progression.
  • Elucidation of mechanisms contributing to therapeutic resistance.

Conclusions:

  • Targeting the bone marrow microenvironment presents a promising therapeutic avenue for multiple myeloma.
  • Understanding cell-host interactions can lead to novel treatment strategies overcoming drug resistance.
  • Biologically based approaches offer potential for improved patient outcomes in multiple myeloma.

More Related Videos

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.